Advertisement
Correspondence| Volume 32, ISSUE 4, P379-380, August 15, 1992

Download started.

Ok

NMDA-Associated glycine binding site increases in schizophrenic brains

DOI:https://doi.org/10.1016/0006-3223(92)90043-Y
NMDA-Associated glycine binding site increases in schizophrenic brains
Previous ArticleSeason-of-birth effect reveals the existence of etiologically different groups of schizophrenia
Next ArticleCorrection: Suspiciousness after i.v. cocaine
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Carlsson M.
        • Carlsson A.
        Schizophrenia: A subcortical neurotransmitter imbalance syndrome?.
        Schizophr Bull. 1990; 16: 425-432
        • Javitt D.C.
        • Zukin S.R.
        Recent advances in the phencyclidine model of schizophrenia.
        Am J Psychiatry. 1991; 148: 1301-1308
        • Johnson J.W.
        • Ascher P.
        Glycine potentiates the NMDA response in cultured mouse brain neurons.
        Nature. 1987; 325: 529-531
        • Kim J.S.
        • Kornhuber H.H.
        • Schmid-Burgk W.
        • et al.
        Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia.
        Neurosci Lett. 1980; 20: 379-382
        • Kleckner N.W.
        • Dingledine R.
        Requirement for glycine in inactivation of NMDA-receptors expressed in Xenopus oocytes.
        Science. 1988; 241: 835-837
        • Kornhuber J.
        • Kornhuber M.E.
        Presynaptic dopaminergic modulation of cortical input to the striatum.
        Life Sci. 1986; 39: 669-674
        • Kornhuber J.
        • Mack-Burkhardt F.
        • Riedere P.
        • et al.
        [3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients.
        J Neural Transm. 1989; 77: 231-236
        • Nishikawa T.
        • Takashima M.
        • Toru M.
        Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia.
        Neurosci Lett. 1983; 40: 245-250
        • Ogita K.
        • Suzuki T.
        • Yoneda Y.
        Strychnine-insensitive binding of [3H]glycine to synaptic membranes in rat brain, treated with Triton X-100.
        Neuropharmacology. 1989; 28: 1263-1270
        • Toru M.
        • Takashima M.
        • Mataga N.
        • et al.
        Hyperdopaminergic and hypoglutamatergic states in postmortem schizophrenic brain.
        Schizophrenia: An Integrative View. 1984; (abs.): 85
        • Toru M.
        • Watanabe S.
        • Shibuya H.
        • et al.
        Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients.
        Acta Psychiatr Scand. 1988; 78: 121-137
        • Utas J.
        • Monaghan D.T.
        • Cotman C.W.
        Plastic responses of hippocampal excitatory amino acid receptors to deafferent and reinnervation.
        Neuroscience. 1990; 34: 9-17
        • Utas J.
        • Monaghan D.T.
        • Cotman C.W.
        Kainate receptors in the rat hippocampus: A distribution and time course of changes in response to unilateral lesions of the entorhinal cortex.
        J Neurosci. 1990; 10: 2352-2362

      Article info

      Identification

      DOI: https://doi.org/10.1016/0006-3223(92)90043-Y

      Copyright

      © 1992 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX